CARD11 signaling regulates CD8⁺ T cell tumoricidal function.

Area of Science:

• Immunology
• Molecular Biology
• Cancer Research

Background:

• Chronic tumor microenvironment stimulation leads to exhausted CD8+ T (T_ex) cells, impairing anti-tumor responses.
• T-cell receptor (TCR) signaling is crucial for T-cell function and differentiation.

Purpose of the Study:

• To investigate the role of T-cell receptor (TCR) signal strength, mediated by CARD11, in T_ex cell differentiation and anti-tumor activity.
• To explore the potential of modulating TCR signaling for enhancing cancer immunotherapy.

Main Methods:

• Utilized patient-derived mutations in the CARD11 protein to manipulate TCR signaling strength.
• Analyzed the impact of varying TCR signaling on T_ex cell differentiation, tumor growth, and TCR repertoire.
• Investigated the mechanistic role of CARD11 in regulating TCR complex homeostasis.

Main Results:

• An inverse correlation was observed between TCR signal strength and T_ex cell differentiation.
• Strong TCR signaling (E134G mutant) inhibited T_ex differentiation, promoting tumor growth.
• Reduced TCR signaling (K215M mutant) enhanced T_ex differentiation and tumor control by restraining the TCR repertoire.

Conclusions:

• CARD11 acts as a TCR signal-strength sensor, controlling the T_ex cell repertoire.
• Fine-tuning CARD11-mediated TCR signaling can expand the TCR repertoire during T_ex differentiation.
• Modulating TCR signal strength offers a promising strategy to reinvigorate anti-tumor function and improve cancer immunotherapy.